Anti-tuberculosis agents may be associated with myelodysplastic syndromes

Kaohsiung J Med Sci. 2019 Oct;35(10):651-652. doi: 10.1002/kjm2.12111. Epub 2019 Aug 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antitubercular Agents / adverse effects*
  • Antitubercular Agents / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / etiology*
  • Tuberculosis / drug therapy

Substances

  • Antitubercular Agents